UK_Head of Market Access & Business Intelligence

Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.

Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the world. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets around the world, Celltrion Group has been securing distribution channels and providing patients with biosimilars at affordable prices.

Overall Purpose of the Role:

The Head of Market Access & Business Intelligence is accountable for the UK market access strategy and execution across Celltrion’s biosimilar portfolio. This role leads all market access activities (national and regional), ensuring optimal patient access and sustainable commercial outcomes through effective engagement with NHS England and commissioning bodies, procurement hubs and trusts, and health policy stakeholders. The post-holder provides leadership and insight across tendering, pricing governance, HTA/NICE guidance, and payer/customer strategy, underpinned by robust business intelligence and compliant stakeholder engagement.

Accountability:

• Market Access Strategy & Delivery: Develop, own and deliver the annual UK Market Access strategy and operating plan for the biosimilars portfolio, aligned to corporate objectives, NHS priorities and the evolving policy environment.

• Access Planning & Stakeholder Engagement: Lead national and regional access planning, including stakeholder mapping, segmentation and engagement plans for NHS procurement bodies across England and the devolved nations, Integrated Care Boards (ICBs), health boards, provider trusts, procurement hubs and key influencers.

• Policy Influence & External Engagement: Monitor, interpret and help shape the UK policy and reimbursement environment through engagement with the Department of Health and Social Care (DHSC), NHS England and relevant stakeholders; represent the organisation in key industry forums including the British Biosimilars Association (BBA), Medicines UK and ABPI working groups, and coordinate engagement with MHRA on biosimilar-specific considerations in partnership with the Responsible Person/QA & Regulatory Affairs teams.

• Competitor Intelligence & Strategic Foresight: Lead systematic competitor intelligence on price positioning and forward-looking policy landscaping, including analysis of Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) and related frameworks, to anticipate market shifts, identify risks and opportunities, and enable proactive, strategically agile decision-making.

• NHS Partnerships & Access Enablement: Build and maintain strategic partnerships with NHS procurement and commissioning stakeholders (including NHS England and CMU/procurement leads), leading biosimilar-specific access initiatives such as switching frameworks, pathway optimisation, and service redesign and implementation resources in collaboration with Medical and system partners.

• Tendering, Contracting & Pricing Governance: Be accountable for tender and contracting outcomes across the UK (NHS and, where applicable, private markets), including ownership of tender pipeline governance, bid/no-bid decisions, pricing governance, scenario planning and senior escalation management, to deliver sustainable revenue, margin and access.

• Commercial Integration & Field Enablement: Provide market access leadership to commercial account teams (RBMs/KAMs), ensuring consistent, compliant and up-to-date value messaging to support biosimilar adoption and switching programmes.

• Cross-functional Alignment & Execution: Partner cross-functionally with Medical, Regulatory Affairs/QA (Responsible Person), Marketing, Supply/Operations and Finance to ensure access strategy, evidence generation and supply plans are aligned and executable.

• Performance Management & Insight Generation: Establish clear governance, reporting and cadence for market access performance (tenders, uptake, share, pricing and guideline alignment), including NICE horizon scanning and implementation tracking; provide regular insights and recommendations to UK leadership.

• Leadership & Organisational Capability: Lead, develop and integrate a multidisciplinary team spanning NHS Collaboration, Business Intelligence (Business Excellence, SFE), and Contracts & Tenders; drive high performance, clear accountability, collaboration and continuous improvement, while informing resource allocation to support departmental growth.

• Compliance, Governance & Risk Management: Ensure all external engagement and activities are conducted in line with ABPI Code of Practice, PMCPA requirements and internal compliance processes; act as a visible role model for compliant behaviours.

Key Responsibilities:

Strategic Leadership & Market Access Planning

• Strategic Market Access Leadership: Lead the UK Market Access function for the biosimilars portfolio, translating brand strategy into executable national and regional access plans, aligned to NHS England and ICB priorities.

• Commissioning & Payer Engagement: Drive commissioning and payer engagement, working closely with NHS England, ICBs, procurement hubs and provider trusts to support access, uptake and switching in line with local governance and best practice.

• NICE & Evidence Strategy: Lead NICE responsibilities end-to-end: horizon scan and assess relevant NICE work programmes (e.g., Technology Appraisals, Highly Specialised Technologies and clinical guidelines); develop internal evidence/value strategies with Medical and HEOR; coordinate any company input to scoping and consultations; lead planning for submissions (where applicable) and responses to requests for information; and translate published guidance into actionable UK implementation plans (formulary, commissioning and pathway implications), including field/brand enablement.

• Market Intelligence & Competitive Insight: Maintain deep understanding of the UK biosimilars landscape, including competitor activity, policy developments, commissioning trends and clinical practice changes; translate insights into opportunities and risk mitigation plans.

Launch, Access Execution & Commercial Operations

• Product Readiness & Market Entry Execution: Lead UK market access operational requirements for successful product launch, including securing PIP codes, managing list price submissions and approvals, ensuring timely inclusion in relevant NHS and commercial pricing databases (e.g. dm+d), and coordinating pre-tender access enablers such as formulary submissions, reimbursement pathway alignment, supply readiness, and compliance with procurement requirements.

• Tendering, Contracting & Pricing Governance: Own tendering and contracting excellence across the biosimilars portfolio; set strategy across NHS Commissioning Frameworks and other procurement routes, define bid/no-bid and pricing guardrails, and lead cross-functional governance through to approval. Oversee submission quality and timelines delivered by the Tenders & Contracts Associate, ensuring robust documentation, compliance and audit readiness; lead senior engagement and escalation with NHS procurement and commissioning stakeholders during tender cycles; and drive continuous improvement through win/loss reviews, contract performance monitoring and risk mitigation, including supply continuity considerations.

• Private Contracting & Commercial Governance: Lead contracting strategy beyond NHS frameworks, including oversight of private healthcare contracting priorities and negotiation approach; partner with Finance/Legal (as applicable) to manage commercial, governance and compliance risks and ensure contracts align with company policies.

• Biosimilar Adoption & Pathway Support: Provide biosimilar pathway leadership, developing materials and support for switching/adoption initiatives with Medical, and ensuring external activities remain compliant and appropriately certified.

External Affairs, Governance & Cross-functional Leadership

• External Affairs & Industry Engagement: Build and maintain relationships with key governance and industry bodies, including the British Biosimilars Association (BBA), ABPI and relevant working groups, ensuring Celltrion’s participation is proactive, coordinated and compliant.

• Regulatory & Safety Pathway Support: In partnership with QA/Regulatory Affairs (Responsible Person), take the lead in supporting biosimilar-specific regulatory and safety pathway considerations, including coordination of MHRA-related topics that impact access, supply or stakeholder communications.

• Cross-functional Governance & Alignment: Lead cross-functional market access governance with Medical, Marketing, Supply/Operations and Finance to ensure strategic alignment, continuity of supply, contracting readiness and consistent external messaging.

• Representation & Internal Enablement: Represent Celltrion at relevant external meetings and forums (including PDIG where applicable) and ensure internal teams are briefed and enabled on outcomes, actions and compliance considerations.

• Compliance & SOP Adherence: Ensure all activities comply with ABPI Code of Practice, PMCPA guidance and internal SOPs, including governance of materials and interactions with external stakeholders.

Performance, Insights & Team Leadership

• Leadership Reporting & Risk Management: Provide regular updates to UK leadership on tender pipeline, contract performance, access barriers/risks and policy changes, with clear recommendations and mitigations.

• Business Intelligence & Insights: Lead the Business Intelligence capability; line manage the Business Intelligence Analyst and ensure timely, accurate insights (market, tender, competitor, pricing and performance) via agreed dashboards and reports to support decision-making.

• People Leadership & Team Development: Line manage the Tenders & Contracts Associate and the NHS & Collaborations lead/direct report, setting clear objectives, developing capability and ensuring robust cross-team ways of working.

Work Experience Requirements:

• Degree in life sciences, pharmacy, health economics, business or a related field, or equivalent experience.

• Significant experience in UK pharmaceuticals/biologics, with strong UK market access responsibility, including tendering, contracting and NHS commissioning.

• Strong understanding of the UK biosimilars market, including procurement environments, access drivers, pricing governance and policy or regulatory considerations.

• Proven ability to engage and influence senior stakeholders across NHS England, ICBs, trusts, procurement bodies and relevant external organisations.

• Experience working with, and/or representing a company through, relevant industry bodies (e.g., BBA, ABPI) and understanding of the UK regulatory landscape (including MHRA) in collaboration with QA/Regulatory.

• Demonstrated leadership experience, including line management, coaching and development of multidisciplinary teams.

• Strong analytical, business intelligence, negotiation and presentation skills, with the ability to translate insight into action.

• ABPI qualification, or willingness to obtain one, with a strong understanding of compliance requirements for external engagement.